User contributions for CHoppe

6 August 2024

• 09:4209:42, 6 August 2024 diff hist +352 Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study No edit summary
• 09:3709:37, 6 August 2024 diff hist −15 Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study No edit summary
• 09:3709:37, 6 August 2024 diff hist +42 Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study No edit summary
• 09:2309:23, 6 August 2024 diff hist +402 Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation No edit summary
• 09:2009:20, 6 August 2024 diff hist −4 Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation No edit summary
• 09:1009:10, 6 August 2024 diff hist +937 Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) No edit summary
• 09:0309:03, 6 August 2024 diff hist +6 Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) No edit summary
• 09:0109:01, 6 August 2024 diff hist +1 Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer No edit summary
• 09:0109:01, 6 August 2024 diff hist +2 Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer No edit summary
• 09:0009:00, 6 August 2024 diff hist +673 Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer No edit summary
• 08:5308:53, 6 August 2024 diff hist +10 Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer No edit summary
• 08:5108:51, 6 August 2024 diff hist +388 Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study No edit summary
• 08:4708:47, 6 August 2024 diff hist +10 Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study No edit summary
• 08:4108:41, 6 August 2024 diff hist +434 Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer No edit summary
• 08:3808:38, 6 August 2024 diff hist +6 Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer No edit summary
• 08:3408:34, 6 August 2024 diff hist −21 Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial No edit summary
• 08:3408:34, 6 August 2024 diff hist +919 Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial No edit summary
• 07:1107:11, 6 August 2024 diff hist +6 Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial No edit summary
• 07:0707:07, 6 August 2024 diff hist −15 Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial No edit summary

30 July 2024

• 12:4912:49, 30 July 2024 diff hist +212 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
• 12:4612:46, 30 July 2024 diff hist 0 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
• 12:4612:46, 30 July 2024 diff hist +334 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
• 12:2012:20, 30 July 2024 diff hist +241 Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma No edit summary
• 12:1712:17, 30 July 2024 diff hist +307 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
• 12:0912:09, 30 July 2024 diff hist +309 Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer No edit summary
• 12:0612:06, 30 July 2024 diff hist +327 Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial No edit summary
• 12:0312:03, 30 July 2024 diff hist +228 Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients No edit summary
• 12:0012:00, 30 July 2024 diff hist +559 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
• 11:4611:46, 30 July 2024 diff hist +540 Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study No edit summary
• 11:4411:44, 30 July 2024 diff hist +254 Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators No edit summary
• 11:4111:41, 30 July 2024 diff hist −19 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 11:4111:41, 30 July 2024 diff hist +19 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 11:3911:39, 30 July 2024 diff hist −37 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 11:3811:38, 30 July 2024 diff hist −43 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 11:3711:37, 30 July 2024 diff hist +656 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 11:2811:28, 30 July 2024 diff hist +73 Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma No edit summary
• 11:2011:20, 30 July 2024 diff hist +131 Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer No edit summary
• 11:1811:18, 30 July 2024 diff hist +349 Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial No edit summary
• 10:5610:56, 30 July 2024 diff hist +1 Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients No edit summary
• 10:5610:56, 30 July 2024 diff hist +53 Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients No edit summary
• 10:4810:48, 30 July 2024 diff hist +451 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
• 10:3910:39, 30 July 2024 diff hist −24 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 10:3610:36, 30 July 2024 diff hist +116 Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study No edit summary
• 10:2410:24, 30 July 2024 diff hist +345 Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators No edit summary
• 10:1710:17, 30 July 2024 diff hist +181 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
• 10:0210:02, 30 July 2024 diff hist +73 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary

5 July 2024

• 11:4511:45, 5 July 2024 diff hist +5,209 Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma No edit summary
• 10:1610:16, 5 July 2024 diff hist +1,749 Publication: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma No edit summary
• 10:0910:09, 5 July 2024 diff hist +9,219 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary

4 July 2024

• 13:5613:56, 4 July 2024 diff hist +2,036 N Publication: Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) Created page with "{{Publication |Title=Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) |Topic=Vitamin D |Author=Shapiro, AC; Adlis, SA; Robien, K; Kirstein, MN; Liang, S; Richter, SA; Lerner, RE |Year=2016 |Journal=Breast cancer Research and Treatment |DOI=10.1007/s10549-016-3710-6 |Authors Abstract=Purpose: To evaluate the efficacy and safety of vitamin D3 at 4,000 IU/day as a treatment option for aromatase inhibitor as..."